A lipid (fat) whose anti-inflammatory activities were discovered by Cardiff University, with colleagues from Universities of Pittsburgh, Oregon and Michigan, is being developed into a new drug for the treatment of diseases ...
Sep 1, 2017
0
2
The deadly condition known as pulmonary arterial hypertension (PAH), which afflicts up to 150,000 Americans each year, may be reversible by using an inhalable gene therapy, report an international team of researchers led ...
Jul 30, 2013
0
0
(Medical Xpress)—The world's leading voices in the fight against pulmonary hypertension have compiled a special publication detailing the breakthrough research into the causes of this debilitating vascular disease.
Jan 6, 2014
0
0
Pulmonary hypertension is an abnormal elevation of pressure in the pulmonary circulation that results in stress on the heart and remodeling of blood vessels in the lung. Pulmonary hypertension is caused by a variety of factors, ...
Jun 2, 2016
0
1
(HealthDay)—For patients with chronic obstructive pulmonary disease (COPD), computed tomographic (CT) measurement of pulmonary artery enlargement, as determined by a ratio of the diameter of the pulmonary artery to the ...
Sep 4, 2012
0
0
A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study published in Lancet Haematology.
Apr 11, 2024
0
29
People with asthma have an increased risk of pulmonary embolism, according to new research.
Dec 19, 2012
0
0
For patients receiving background therapy for pulmonary arterial hypertension, treatment with sotatercept results in a reduction in pulmonary vascular resistance, according to a study published in the April 1 issue of the ...
Apr 1, 2021
0
5
A number of studies have already shown that malnutrition during pregnancy may increase the risk of developing type 2 diabetes later on in life. According to a 2013 study by Peter Klimek and his team, people born during a ...
Jul 20, 2023
0
25
The development of new, more effective vasodilators to treat pulmonary arterial hypertension (PAH) has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking ...
Jan 7, 2014
0
0
